The Imperial iGEM 2026 team, reGelerate, is preparing to compete in the International Genetically Engineered Machine (iGEM), the world’s largest annual synthetic biology contest. Bringing together interdisciplinary student teams from across the globe, iGEM challenges participants to develop innovative research projects that address real-world issues in areas such
Competing for a share of £30,000 worth of funding, the five finalists for the WE Innovate pre-accelerator program represent the best of tech enterprise from across the UK, narrowed down from over 200 applicants. The final five included start-ups from across Imperial business community, including biotech, e-
A fortnight ago, South Kensington campus and surroundings became a riot of colour, crowds, and scientific communication. 57,000 people attended the Great Exhibition Road festival, which ran on the 19th and 20th of June, marking 175 years since the Great Exhibition in 1851. The festival is subdivided into ‘zones’
Understanding the recent MV Hondius outbreak reveals how viruses can adapt to new hosts.
A team of researchers at Imperial believes that a breathalyser-style test could help detect pancreatic cancer earlier.
We can’t, obviously: the ethical concerns place this firmly in dystopian science fiction territory. Yet, the Yale spinout startup Bexorg is offering something very close. The team created a proprietary system which takes brains removed from deceased people who choose to donate their bodies to science and connect them
Imperial-based team prepares to break altitude record for liquid bipropellant rockets.
The Evo 2 project uses AI to develop a novel bacteriophage.
In a proof-of-concept study, researchers at Imperial have tested VeloCD, a bioinformatics-based method that successfully predicts illness progression and treatment efficacy using RNA markers in blood. Their research found that the test could accurately predict disease trajectories and future infection status in controlled human challenge studies for
With the rise of social media, the world is at our fingertips. With one swipe, you can see footage from anywhere, at any time, and for the first time in history, endless amounts of information and entertainment are readily available to us. However, as we all know, one swipe can
How do Imperial students and researchers at different stages of their career view and explore immunology?
As students at a university that has long prided itself in its research and innovation, it is inevitable to ask ourselves throughout our degree how exciting breakthroughs materialise into products on the market. The business component of discovery is therefore paramount to its success, which Imperial reflects in its STEMB